Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1. - Wikidata - wikimedia - TriplyDB

Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.

Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.

http://www.wikidata.org/entity/Q33971359

about

Inflammation causes mood changes through alterations in subgenual cingulate activity and mesolimbic connectivity The type 1 TNF receptor and its associated adapter protein, FAN, are required for TNFalpha-induced sickness behavior.Cytokine, sickness behavior, and depression The role of TNF-alpha in fever: opposing actions of human and murine TNF-alpha and interactions with IL-beta in the rat Twenty years of research on cytokine-induced sickness behavior Inflammation Models of Depression in Rodents: Relevance to Psychotropic Drug Discovery IL-1 receptor 2 (IL-1R2) and its role in immune regulation Alcoholism and inflammation: neuroimmunology of behavioral and mood disorders PKR deficiency alters E. coli-induced sickness behaviors but does not exacerbate neuroimmune responses or bacterial load Inhibition of vagally mediated immune-to-brain signaling by vanadyl sulfate speeds recovery from sickness.Accelerated recovery from acute hypoxia in obese mice is due to obesity-associated up-regulation of interleukin-1 receptor antagonist.Neurobiology of inflammation-associated anorexia.Sex-specific social regulation of inflammatory responses and sickness behaviors.Effects of insulin-like growth factor-I on cytokine-induced sickness behavior in mice.Cytokine, sickness behavior, and depression.Hypothalamic mechanisms in cachexia.Malaise in the water maze: untangling the effects of LPS and IL-1beta on learning and memory.Prenatal immune challenge alters the hypothalamic-pituitary-adrenocortical axis in adult rats.Cytokines and the anorexia of infection: potential mechanisms and treatments.Tumor necrosis factor-alpha triggers a cytokine cascade yielding postoperative cognitive decline Interleukin (IL) 1beta, IL-1 receptor antagonist, IL-10, and IL-13 gene expression in the central nervous system and anterior pituitary during systemic inflammation: pathophysiological implications Dynamic and extensive metabolic state-dependent regulation of cytokine expression and circulating levels Suppression of the febrile response in late gestation: evidence, mechanisms and outcomes.Fatigue in cholestatic liver disease--a perplexing symptom Neuroinflammation and memory: the role of prostaglandins Corticotropin releasing factor-1 receptor antagonism alters the biochemical, but not behavioral effects of repeated interleukin-1β administration.Macrophages make me sick: how macrophage activation states influence sickness behavior Functional role for interleukin-1 in the injured peripheral taste system.Suppression of Locomotor Activity in Female C57Bl/6J Mice Treated with Interleukin-1β: Investigating a Method for the Study of Fatigue in Laboratory Animals.Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents.Sickness behavior in feverish children is independent of the severity of fever. An observational, multicenter study Acute illness-induced behavioral alterations are similar to those observed during withdrawal from acute alcohol exposure Neonatal programming of innate immune function Environmental context differentially affects behavioral, leukocyte, cortisol, and interleukin-6 responses to low doses of endotoxin in the rhesus monkey.Prostaglandin-dependent modulation of dopaminergic neurotransmission elicits inflammation-induced aversion in mice.Postnatal inflammation increases seizure susceptibility in adult rats.PPARγ activation prevents impairments in spatial memory and neurogenesis following transient illness Evidence for IL-1 receptor blockade as a therapeutic strategy for the treatment of depression.Acute hypoxia, diabetes, and neuroimmune dysregulation: converging mechanisms in the brain.Photoperiodic regulation of behavioral responsiveness to proinflammatory cytokines.

P2860

Q24634258-08178A70-078A-4708-BCD9-56A34FFCF43C Q24648146-907495A0-4014-407D-A76F-DF238ABFD9E4 Q24657818-627E3CAB-E836-4B53-910B-242C26BF2CF3 Q24679558-F9712C94-F97C-46F4-95AB-E3A696E6A63D Q24684760-5379A9C4-61D9-4816-A53F-FD02834B7B26 Q26749497-C4F0D144-565F-4042-B8CA-CCA95B048739 Q26826872-779E4FAE-37AA-453D-86D3-CE4CF63D0F57 Q28302013-7EF0C59F-166C-4D6F-AB96-ECB24663AB5A Q30398450-484AB2B3-5E01-4504-98B0-5396D04CB96A Q30476283-9D544035-CBA2-40C2-AD6A-25BA08E0FFB3 Q30487953-7657D2DE-D57E-42C6-AA73-671C1D372444 Q33806456-3175E9E7-841D-490E-A367-C45B66C5BB6A Q33965347-F6D878A5-4BDC-4516-B5FD-E127DFA9B3AB Q34007543-B2E92DDB-ACA8-46CE-A705-1D5FE91A1048 Q34018621-6A149726-E3BB-43D6-A68D-07378660CC40 Q34081332-69FB0429-F7EE-423B-8021-66559D5901C1 Q34147135-A4EE48CC-4CEC-4C94-A4E4-8DB2EF2432E3 Q34152637-99516D5E-980D-4E2E-A9F7-FD115DB84E7E Q34170497-43AB0F50-9866-4677-B570-D740A628512B Q34377379-6B9333AB-3E35-475E-98C1-9818A47FD548 Q34413004-32748387-1BF2-4AA0-A022-8B2CB41FB620 Q34726647-1663DAA1-94A2-4FD8-B202-F1A75284379F Q34749075-509A8EB0-8549-4499-BC7A-46622DA79E85 Q34769039-F20F977D-4AEA-4DE8-8F77-17489EAA3AE5 Q35072707-985E881E-E161-4C73-89FC-9E86702CCD95 Q35380856-458A129F-25A6-4AB1-8F29-C4563DA7AC16 Q35421025-0CF6D286-DB98-4C39-9C2D-F0A1F711CEA0 Q35742815-FF7CC30B-A6EF-40F7-AEA2-2373177B4620 Q35808819-A2424DE7-19B0-44BD-BDA5-9FAFFC39CDC2 Q36052673-03B13686-9FF5-4368-BADF-CBAFA0861C60 Q36302366-EFA93262-AD9F-495A-9541-C3538B54B866 Q36388900-19014747-CF8F-4141-BB79-54948DEC9CD6 Q36472375-41ECC74B-7B99-4C53-85C6-80170E67C938 Q36514175-211CBC91-A63B-48D2-919A-4BFC370FEA4B Q36515078-86D628EF-560A-4ACE-A25B-2C2B35B5E568 Q36542199-5F1A3A04-8C9F-4E5C-A826-4E263DB3A466 Q36605328-4CA87A65-D9B1-47CF-8852-AB99126B636D Q36904522-D714A119-5678-4453-9E84-A25039067B86 Q37000203-41D1A13A-CA92-4787-B08A-0E4E865F14F5 Q37217343-C87E1694-6CFB-4E0D-A7CE-E42014F6461D

P2860

Different receptor mechanisms mediate the pyrogenic and behavioral effects of interleukin 1.

http://www.wikidata.org/entity/Q33971359

description

1992 nî lūn-bûn

@nan

1992 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած

@hyw

1992 թվականի հոտեմբերին հրատարակված գիտական հոդված

@hy

1992年の論文

@ja

1992年論文

@yue

1992年論文

@zh-hant

1992年論文

@zh-hk

1992年論文

@zh-mo

1992年論文

@zh-tw

1992年论文

@wuu

name

Different receptor mechanisms ...... oral effects of interleukin 1.

@ast

Different receptor mechanisms ...... oral effects of interleukin 1.

@en

type

label

Different receptor mechanisms ...... oral effects of interleukin 1.

@ast

Different receptor mechanisms ...... oral effects of interleukin 1.

@en

prefLabel

Different receptor mechanisms ...... oral effects of interleukin 1.

@ast

Different receptor mechanisms ...... oral effects of interleukin 1.

@en

P1433

Q33971359-BEE633F2-9910-4F16-B671-5B99CB3923DA

P1476

Q33971359-9C4430B0-DDF1-4D95-BA1F-CBD9D63A4DDA

P2093

Q33971359-07B71862-2D74-47F8-B68C-9A664B06FD83

Q33971359-15F4DAF9-FC82-4B85-83B5-E2085B5A28A7

Q33971359-43426761-77BE-4F3A-AA73-B6F01648C32E

Q33971359-A94E3F4A-061F-450C-B976-AC3F3B4919D2

Q33971359-B8EA648B-9EBC-421D-8AE8-FF4167880D5F

Q33971359-DD7EC5CA-4279-4009-B1D5-B6965A1BFF87

Q33971359-EF71C327-77D9-42D9-9651-0952A8EFBDAA

P2860

Q33971359-081FECEA-E5A9-4339-BDBE-B5A4CB31EAF8

Q33971359-21A539C5-897F-4A4E-9D6A-DCB4ABE64411

Q33971359-28A9A441-9598-4F3E-AF9B-30B9CEF82A8C

Q33971359-2938BC69-A8A2-4DB8-89B7-8174B047C475

Q33971359-2F029DB6-5FD0-43B2-9857-0DD45458E5BD

Q33971359-2FD2BAA5-B2FB-4E86-9462-85E8FD8DA1F3

Q33971359-2FF262A1-C688-4F7D-A966-7420B6604C05

Q33971359-35CE2A32-310A-4BA6-9F60-AC5307C1F138

Q33971359-3D8A7322-C3B0-4667-9F33-6FA949A30A31

Q33971359-3DEC29E6-68C9-4DFC-B3DE-314E82313259

P304

Q33971359-910A3D40-8C3F-44FD-951A-2B3F379FF541

P31

Q33971359-E7A407AB-801A-4672-9EBD-C11BBD502C21

P356

Q33971359-D7253C90-9C80-427C-B6F6-294E3DEBAE81

P407

Q33971359-FBDCE60E-5DC9-4F29-A555-6CBFB206CD96

P433

Q33971359-F93A6CB2-0003-4390-B615-F4FFB71CF278

P478

Q33971359-CD993F5A-D559-46F3-98F6-AB963E415A85

P577

Q33971359-095AED04-1F05-4910-8E37-214E7DC869D2

P5875

Q33971359-8B550DE3-16B1-4DA4-B540-0D6E01C72ABD

P698

Q33971359-0E54A06C-E237-4922-9E55-F149D2E3A0BF

P932

Q33971359-E5740C1F-338C-4F08-914E-4E5C2AA6302F

P356

PNAS.89.19.9117

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Different receptor mechanisms ...... oral effects of interleukin 1.

@en

P2093

A J Hardwick

http://www.w3.org/2001/XMLSchema#string

J L Vannice

http://www.w3.org/2001/XMLSchema#string

K W Kelley

http://www.w3.org/2001/XMLSchema#string

N J Rothwell

http://www.w3.org/2001/XMLSchema#string

R Dantzer

http://www.w3.org/2001/XMLSchema#string

R M Bluthe

http://www.w3.org/2001/XMLSchema#string

S Kent

http://www.w3.org/2001/XMLSchema#string

P2860

Interleukin-1 receptor antagonist activity of a human interleukin-1 inhibitor

A novel IL-1 receptor, cloned from B cells by mammalian expression, is expressed in many cell types

Interleukin-1 receptor antagonist binds to the type II interleukin-1 receptor on B cells and neutrophils

Primary structure and functional expression from complementary DNA of a human interleukin-1 receptor antagonist.

Biological basis of the behavior of sick animals.

Biological properties of recombinant human monocyte-derived interleukin 1 receptor antagonist.

Two high-affinity interleukin 1 receptors represent separate gene products.

Interleukin-1-induced anorexia in the rat. Influence of prostaglandins.

Sickness behavior as a new target for drug development.

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody.

P304

9117-9120

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.89.19.9117

http://www.w3.org/2001/XMLSchema#string

P407

P433

19

http://www.w3.org/2001/XMLSchema#string

P478

89

http://www.w3.org/2001/XMLSchema#string

P577

1992-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

21745327

http://www.w3.org/2001/XMLSchema#string

P698

1409612

http://www.w3.org/2001/XMLSchema#string

P932

50076

http://www.w3.org/2001/XMLSchema#string